CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection

被引:157
作者
Afford, SC [1 ]
Randhawa, S
Eliopoulos, AG
Hubscher, SG
Young, LS
Adams, DH
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Inst Clin Sci, Liver Res Labs, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Sch Med, CRC, Inst Canc Studies, Birmingham B15 2TJ, W Midlands, England
[3] Univ Birmingham, Dept Pathol, Birmingham B15 2TT, W Midlands, England
基金
英国惠康基金;
关键词
CD40; activation; apoptosis; hepatocytes; allograft rejection;
D O I
10.1084/jem.189.2.441
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We propose that a novel mechanism of hepatocyte apoptosis, involving a cooperative interaction between CD40 and Fas, is involved in the hepatocyte loss of chronic liver allograft rejection. We detected increased hepatocyte expression of Fas, Fas ligand (FasL), and CD40 associated with dropout of centrilobular (acinar zone 3) hepatocytes in chronic allograft rejection. Expression of CD40 ligand (CD40L) was also increased but was largely restricted to CD68(+) macrophages. A functional role for CD40 and Fas in hepatocyte apoptosis was demonstrated in vitro using primary human hepatocytes and the HepG2 cell, line in both of which apoptosis was induced, not only by cross-linking Fas directly but also via CD40 activation. Our data suggest that CD40 activation induces apoptosis via Fas because (a) ligation of CD40 upregulated hepatocyte Fast expression, and (b) apoptosis induced via activation of CD40 was prevented by a neutralizing monoclonal antibody to Fast. Thus, CD40 engagement triggers apoptosis of human hepatocytes and might amplify Fas-dependent hepatocyte apoptosis in chronic rejection and other inflammatory liver diseases in which Fas-mediated apoptosis is involved.
引用
收藏
页码:441 / 446
页数:6
相关论文
共 28 条
[1]  
ADAMS DH, 1991, HEPATOLOGY, V14, P426, DOI 10.1002/hep.1840140305
[2]  
ADAMS DH, 1989, LANCET, V2, P1122
[3]  
ADAMS DH, 1995, 5 INT WORKSH LEUK DI
[4]   APOPTOSIS IN THE HUMAN LIVER DURING ALLOGRAFT-REJECTION AND END-STAGE LIVER-DISEASE [J].
AFFORD, SC ;
HUBSCHER, S ;
STRAIN, AJ ;
ADAMS, DH ;
NEUBERGER, JM .
JOURNAL OF PATHOLOGY, 1995, 176 (04) :373-380
[5]   INSITU END-LABELING DETECTS DNA STRAND BREAKS IN APOPTOSIS AND OTHER PHYSIOLOGICAL AND PATHOLOGICAL STATES [J].
ANSARI, B ;
COATES, PJ ;
GREENSTEIN, BD ;
HALL, PA .
JOURNAL OF PATHOLOGY, 1993, 170 (01) :1-8
[6]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[7]  
Eliopoulos AG, 1996, ONCOGENE, V13, P2243
[8]  
Gallop JR, 1995, CERN REPORT, V95, P1
[9]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[10]   Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes [J].
Guidotti, LG ;
Ishikawa, T ;
Hobbs, MV ;
Matzke, B ;
Schreiber, R ;
Chisari, FV .
IMMUNITY, 1996, 4 (01) :25-36